Outcomes of Intravitreal Dexamethasone Implant or Anti-VEGF Therapy Combined With Cataract Surgery in Patients With Diabetic Macular Edema
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Eye (London, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Intravitreal dexamethasone implant versus anti-vascular endothelial growth factor therapy combined with cataract surgery in patients with diabetic macular oedema: a systematic review with meta-analysis
Eye (Lond) 2022 Dec 01;36(12)2239-2246, M Fallico, A Lotery, A Maugeri, G Favara, M Barchitta, A Agodi, A Russo, A Longo, V Bonfiglio, T Avitabile, P Marolo, E Borrelli, G Parisi, G Cennamo, C Furino, M ReibaldiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.